Alain Lescoat

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

Francesco Del Galdo, Alain Lescoat, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2024 · 215 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Muriel Elhaï, Marouane Boubaya, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2019 · 188 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease

Alain Lescoat, M Lelong, Mohamed Jeljeli et al. · Biochemical Pharmacology · 2020 · 185 citations

Medicine, Immunology, Pharmacology +14

Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis

Alain Lescoat, Alice Ballerie, M Lelong et al. · Frontiers in Immunology · 2020 · 84 citations · Full text

Life Sciences, Immunology, Pathology +15

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort

Sara Jaafar, Alain Lescoat, Suiyuan Huang et al. · Arthritis Research & Therapy · 2021 · 69 citations · Full text

Life Sciences, Immunology, Internal Medicine +17